Thyrotropin Alfa
Thyrotropin alfa is a recombinant human TSH that stimulates thyroid remnant tissue to take up radioiodine or produce thyroglobulin without requiring the patient to undergo thyroid hormone withdrawal and hypothyroidism. It is used as an adjunct for radioiodine ablation of thyroid remnants and for diagnostic whole-body scanning and serum thyroglobulin testing in differentiated thyroid cancer patients. Its use maintains quality of life by avoiding the morbidity of hypothyroidism during follow-up.
治疗领域
作用机制
As a recombinant protein, it replicates the function of the naturally occurring human protein, supplementing or replacing deficient endogenous production to restore normal physiological activity.
Pharmacokinetics (PK)
Pharmacodynamics (PD)
As a recombinant protein, it replicates the function of the naturally occurring human protein, supplementing or replacing deficient endogenous production to restore normal physiological activity.
HBD / HBA
- / -
No targets recorded
Target interaction data is not yet available for this drug.
No interactions recorded
Drug interaction data is not yet available for this compound.
No side effects recorded
Side effect data is not yet available for this drug.
常见问题
Thyrotropin alfa is a recombinant human TSH that stimulates thyroid remnant tissue to take up radioiodine or produce thyroglobulin without requiring the patient to undergo thyroid hormone withdrawal and hypothyroidism. It is used as an adjunct for radioiodine ablation of thyroid remnants and for diagnostic whole-body scanning and serum thyroglobulin testing in differentiated thyroid cancer patients. Its use maintains quality of life by avoiding the morbidity of hypothyroidism during follow-up.
As a recombinant protein, it replicates the function of the naturally occurring human protein, supplementing or replacing deficient endogenous production to restore normal physiological activity.
Yes, Thyrotropin Alfa is an approved drug. It has reached clinical phase 4. It is classified as a Protein.
References & Data Sources
- ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1201533. Open-access bioactivity database.
Data aggregated from publicly available pharmacological databases. Last updated 2026-02-27.
Embed This Widget
Add the script tag and a data attribute to embed this widget.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<div data-drugfyi="drug" data-slug="thyrotropin-alfa"></div>Embed via iframe for maximum compatibility.
<iframe src="https://drugfyi.com/iframe/drug/thyrotropin-alfa/" width="420" height="400" frameborder="0" style="border:0;border-radius:10px;max-width:100%" loading="lazy"></iframe>Paste this URL in WordPress, Medium, or any oEmbed-compatible platform.
https://drugfyi.com/drug/thyrotropin-alfa/Add a dynamic SVG badge to your README or docs.
[](https://drugfyi.com/drug/thyrotropin-alfa/)Use the native HTML custom element.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<drugfyi-drug slug="thyrotropin-alfa"></drugfyi-drug>